Jürgen Raths
Corporate Officer/Principal chez Executive Insight AG
Postes actifs de Jürgen Raths
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Executive Insight AG | Corporate Officer/Principal | 01/01/2015 | - |
Historique de carrière de Jürgen Raths
Anciens postes connus de Jürgen Raths
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PAION AG | Directeur des opérations | 31/08/2015 | 01/03/2017 |
Advanz Pharma Switzerland SARL
 Advanz Pharma Switzerland SARL Pharmaceuticals: MajorHealth Technology Advanz Pharma Switzerland SARL manufactures and wholesales pharmaceuticals. The company is headquartered in Geneva, Switzerland. | Directeur Général | 01/01/2010 | 01/01/2013 |
| President | 01/01/2010 | 01/01/2013 | |
Arpida AG
 Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | President | 01/05/2008 | 14/12/2009 |
| Eli Lilly (Suisse) SA | Corporate Officer/Principal | 01/01/1990 | 01/01/2008 |
Vesselon, Inc.
 Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT. | Directeur/Membre du Conseil | - | - |
Formation de Jürgen Raths
| University of Bonn | Doctorate Degree |
Statistiques
Internationale
| Suisse | 5 |
| Allemagne | 3 |
| Etats-Unis | 2 |
Opérationnelle
| President | 2 |
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PAION AG | Health Technology |
| Entreprise privées | 5 |
|---|---|
Arpida AG
Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Health Technology |
Advanz Pharma Switzerland SARL
Advanz Pharma Switzerland SARL Pharmaceuticals: MajorHealth Technology Advanz Pharma Switzerland SARL manufactures and wholesales pharmaceuticals. The company is headquartered in Geneva, Switzerland. | Health Technology |
| Eli Lilly (Suisse) SA | |
| Executive Insight AG | |
Vesselon, Inc.
Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT. | Health Technology |
- Bourse
- Insiders
- Jürgen Raths
- Expérience
